Posner Brian S — SEC insider filings

SEC reporting owner CIK 1372455. 25 insider filings on record with FilingPulse; latest filed 2026-10-06.

Transaction summary — filings shown

Covers all 25 filings on record, filed 2021-05-10 to 2026-10-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ARCH CAPITAL GROUP LTD. (ACGL)Director143 legs · 5,000 sh · $90,9884 legs · 12,000 sh · $245,5799
Dyne Therapeutics, Inc. (DYN)Director98 legs · 18,500 sh · $314,840—2
BIOGEN INC. (BIIB)Director2—1 leg · 360 sh · $98,7011

Insider filings — Posner Brian S

FiledFormIssuerReported transactionsSource
2026-10-064Dyne Therapeutics, Inc. (DYN)Purchase (P): 2,500 @ $16EDGAR
2026-06-094Dyne Therapeutics, Inc. (DYN)Purchase (P): 2,000 @ $16.94 · Grant/award (A): 35,152 (derivative) @ $0EDGAR
2026-06-054Dyne Therapeutics, Inc. (DYN)Purchase (P): 2,500 @ $17.48EDGAR
2026-06-044ARCH CAPITAL GROUP LTD. (ACGL)Sale (S): 3,000 @ $19.66EDGAR
2026-05-284Dyne Therapeutics, Inc. (DYN)Purchase (P): 2,000 @ $18.21EDGAR
2026-05-224Dyne Therapeutics, Inc. (DYN)Purchase (P): 2,500 @ $17.12EDGAR
2026-05-124ARCH CAPITAL GROUP LTD. (ACGL)Sale (S): 2,000 @ $17.14EDGAR
2026-05-074ARCH CAPITAL GROUP LTD. (ACGL)Grant/award (A): 2,071EDGAR
2026-04-014Dyne Therapeutics, Inc. (DYN)Purchase (P): 2,000 @ $17.08EDGAR
2026-03-134Dyne Therapeutics, Inc. (DYN)Purchase (P): 2,000 @ $19.35EDGAR
2026-03-124ARCH CAPITAL GROUP LTD. (ACGL)Sale (S): 3,000 @ $17.11EDGAR
2026-03-104Dyne Therapeutics, Inc. (DYN)Purchase (P): 3,000 @ $15.06EDGAR
2025-10-024Dyne Therapeutics, Inc. (DYN)Grant/award (A): 70,000 (derivative) @ $0EDGAR
2025-08-044ARCH CAPITAL GROUP LTD. (ACGL)Purchase (P): 1,000 @ $17.34EDGAR
2025-05-094ARCH CAPITAL GROUP LTD. (ACGL)Grant/award (A): 1,564EDGAR
2024-05-134ARCH CAPITAL GROUP LTD. (ACGL)Grant/award (A): 1,455EDGAR
2023-05-084ARCH CAPITAL GROUP LTD. (ACGL)Grant/award (A): 1,714EDGAR
2022-11-014ARCH CAPITAL GROUP LTD. (ACGL)Purchase (P): 2,000 @ $17.60EDGAR
2022-05-064ARCH CAPITAL GROUP LTD. (ACGL)Grant/award (A): 2,642 · Grant/award (A): 2,642EDGAR
2022-05-024ARCH CAPITAL GROUP LTD. (ACGL)Purchase (P): 2,000 @ $19.23EDGAR
2021-10-014ARCH CAPITAL GROUP LTD. (ACGL)Disposition to issuer (D): 2,000 @ $25EDGAR
2021-07-024BIOGEN INC. (BIIB)Grant/award (A): 775 @ $0EDGAR
2021-06-154ARCH CAPITAL GROUP LTD. (ACGL)Sale (S): 4,000 @ $25.24EDGAR
2021-06-074BIOGEN INC. (BIIB)Sale (S): 360 @ $274.17EDGAR
2021-05-104ARCH CAPITAL GROUP LTD. (ACGL)Grant/award (A): 3,143 · Grant/award (A): 3,143EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-05-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1372455 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs